血管内皮生长因子C靶向分子探针在肝细胞癌大鼠模型中的特异性磁共振成像及临床意义

潘奇; 罗春海; 马婉玲; 曲原飞; 王建如; 陈琳

doi:10.3969/j.issn.1001-5256.2018.07.025

血管内皮生长因子C靶向分子探针在肝细胞癌大鼠模型中的特异性磁共振成像及临床意义

DOI: 10.3969/j.issn.1001-5256.2018.07.025

1. 西安医学院第二附属医院影像科
2. 空军军医大学西京医院放射科
3. 西安医学院第二附属医院妇科

基金项目:

陕西省科技厅社发攻关项目(2016SF-295)；陕西省教育厅专项科研资助项目(16JK1662)；西安医学院第二附属医院科研项目(16KY0110)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1995
- HTML全文浏览量: 53
- PDF下载量: 343
- 被引次数: 0
出版历程
- 收稿日期: 2018-01-25
- 出版日期: 2018-07-20

Specific magnetic resonance imaging of vascular endothelial growth factor-C targeted molecular probe and its clinical significance in a rat model of hepatocellular carcinoma

Department of Radiology, The Second Affiliated Hospital of Xi'an Medical College

Research funding:

摘要

摘要: 目的观察血管内皮生长因子C（VEGF-C）抗体与超顺磁性氧化铁颗粒（USPIO）连接的靶向分子探针（VEGF-C-USPIO）在大鼠肝细胞癌（HCC）模型体内的MR成像特点,并探讨其临床意义。方法采用诱导法建立大鼠原位肝癌模型,将30只SD大鼠随机分为实验组（n=20）和对照组（n=10）。分别于鼠尾静脉注射靶向探针VEGF-C-USPIO和非靶向探针USPIO,并于注射前及注射后1 h对大鼠行MR扫描成像,测量其肝脏肿瘤与周围肝组织的T2WI信号强度,计算噪声比（CNR）,比较增强前后2组之间CNR的差异。扫描结束后取动物肝脏进行HE染色明确大鼠肝癌病理类型;普鲁士蓝染色验证肿瘤组织细胞中铁含量;免疫组化染色验证肝癌组织中VEGF-C的表达情况。实验组与对照组间的比较采用独立样本t检验,实验组或对照组内注射对比剂前后的比较采用配对样本t检验。结果 30只大鼠全部诱癌成功,病理学诊断为HCC,成瘤率100%。实验组注射靶向对比剂VEGF-C-USPIO后1 h与注射前CNR比较,差异有统计学意义（2.11±0.23 vs 3.47±0.45,t=-13.15,P<0.001）;对...
- 癌,肝细胞 /
- 血管内皮生长因子C /
- 磁共振成像 /
- 超小型超顺磁性氧化铁 /
- 大鼠,Sprague-Dawley
Abstract: Objective To investigate the magnetic resonance ( MR) imaging features of the targeted molecular probe with vascular endothelial growth factor-C ( VEGF-C) antibody and superparamagnetic iron oxide ( USPIO) , VEGF-C-USPIO, in a rat model of hepatocellular carcinoma ( HCC) and its clinical significance. Methods The induction method was used to establish a rat model of in situ HCC, and30 Sprague-Dawley rats were randomly divided into experimental group with 20 rats and control group with 10 rats. The rats in the experimental group were treated with tail vein injection of the targeted molecular probe VEGF-C-USPIO, and those in the control group were treated with tail vein injection of the non-targeted probe USPIO. MR scanning was performed before injection and at 1 hour after injection;the intensity of T2 WI signal in liver tumor and adjacent liver tissue was measured; contrast-to-noise ratio ( CNR) was calculated, and the two groups were compared in terms of CNR before and after enhancement. Liver tissue was collected after scanning, and HE staining was performed to clarify the pathological type of liver cancer in rats; Prussian blue staining was performed to analyze the content of iron in tumor cells; immunohistochemical staining was performed to investigate the expression of VEGF-C in liver cancer tissue. The independent samples t-test was used for comparison between the experimental group and the control group, and the paired samples t-test was used for comparison within each group after the injection of contrast agent. Results Cancer was successfully induced in all 30 rats; the pathological diagnosis was HCC, and the tumor formation rate was 100%. The experimental group had a significant change in CNR at 1 hour after the injection of the targeted contrast agent VEGF-C-USPIO ( 2. 11 ± 0. 23 vs 3. 47 ± 0. 45, t =-13. 15, P < 0. 001) , while the control group had no significant change in CNR at 1 hour after the injection of the non-targeted contrast agent USPIO ( 3. 51 ± 0. 14 vs 3. 82 ± 0. 61, t =-1. 40, P = 0. 192) ; there was a significant difference in CNR between the two groups after injection ( t = 17. 60, P < 0. 001) . HE staining performed for liver tissue samples showed a pathological type of HCC; immunohistochemical staining showed that VEGF-C was mainly expressed in the membrane and cytoplasm of hepatoma cells; Prussian blue staining showed that compared with the control group, the experimental group had a significant increase in iron particles in tumor tissue. Conclusion The synthesized targeted molecular probe VEGF-C-USPIO has a good active targeting effect on a rat model of HCC and can realize the specific imaging of HCC through the change in MR signal intensity. Therefore, it provides an imaging basis for the early diagnosis of HCC.
- carcinoma, hepatocellular /
- vascular endothelial growth factor C /
- magnetic resonance imaging /
- ultrasmall superparamagnetic iron oxide nanoparticles /
- rats, Sprague-Dawley

HTML全文

参考文献(18)

[1]SIEGEL RL, MILLER KD, JEMAL A.Cancer statistics, 2016[J].CA Cancer J Clin, 2016, 66 (1) :7-30.

[2]CHOU R, CUEVAS C, FU R, et al.Imaging techniques for the diagnosis of hepatocellular carcinoma:A systematic review and meta-analysis[J].Ann Intern Med, 2015, 162 (10) :697-711.

[3]ZHANG CY, FU Y, LI XD, et al.Advances in imaging diagnosis of liver cancer[J].J Clin Hepatol, 2017, 33 (7) :1266-1269. (in Chinese) 张春雨, 付宇, 李晓东, 等.肝癌的影像学诊断进展[J].临床肝胆病杂志, 2017, 33 (7) :1266-1269.

[4]International Consensus Group for Hepatocellular Neoplasia.Pathologic diagnosis of early hepatocellular carcinoma:A report of the international consensus group for hepatocellular neoplasia[J].Hepatology, 2009, 49 (2) :658-664.

[5]LIU J, CHENG Y, HE M, et al.Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein[J].Gynecol Endocrinol, 2014, 30 (6) :461-465.

[6]SONG JH, YU DX, FANG JJ, et al.Specific MR imaging of hepatocellular carcinoma using AFP-targeted USPIO molecular probe[J].Chin J Hepatobiliary Surg, 2012, 18 (8) :618-622. (in Chinese) 宋吉慧, 于德新, 方娟娟, 等.甲胎蛋白靶向USPIO分子探针在肝癌特异性磁共振成像中的价值[J].中华肝胆外科杂志, 2012, 18 (8) :618-622.

[7]EFFENDI K, SAKAMOTO M.Molecular pathology in early hepatocarcinogenesis[J].Oncology, 2010, 78 (2) :157-160.

[8]MA L, JI L, YU Y, et al.Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma[J].Discov Med, 2015, 19 (102) :7-14.

[9] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.

[10]BHARALI DJ, MOUSA SA.Emerging nanomedicines for early cancer detection and improved treatment:Current perspective and future promise[J].Pharmacol Ther, 2010, 128 (2) :324-335.

[11]OGHABIAN MA, FARAHBAKHSH NM.Potential use of nanoparticle based contrast agents in MRI:A molecular imaging perspective[J].J Biomed Nanotechnol, 2010, 6 (3) :203-213.

[12]MA KS, JIANG JY.Application of tissue-specific magnetic resonance imaging contrast agent gadolinium ethoxybenzyl dimeglumine on precision hepatic surgery[J].Chin J Dig Surg, 2017, 16 (2) :124-129. (in Chinese) 马宽生, 蒋家云.钆塞酸二钠增强MRI检查在精准肝脏外科中的应用[J].中华消化外科杂志, 2017, 16 (2) :124-129.

[13]SUN Y, ZHENG YY, WU W, et al.Influence of superparamagnetic iron oxide loaded polymermicrospheres on enhanced MRI for liver cancer of rabbits[J].Chin J Med Imaging Technol, 2012, 28 (8) :1445-1448. (in Chinese) 孙阳, 郑元义, 吴伟, 等.载超顺磁性氧化铁高分子微球对兔肝癌MR成像效果的影响[J].中国医学影像技术, 2012, 28 (8) :1445-1448.

[14]ISLAM T, JOSEPHSON L.Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles[J].Cancer Biomark, 2009, 5 (2) :99-107.

[15]YAMAGUCHI R, YANO H, NAKASHIMA O, et al.Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2006, 21 (1 Pt 1) :152-160.

[16]MORITA Y, MORITA N, HATA K, et al.Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-c and lymph node metastasis in human oral tongue cancer[J].Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117 (4) :502-510.

[17]CHEN Y, ZHOU Q, LI X, et al.Ultrasmall paramagnetic iron oxide nanoprobe targeting epidermal growth factor receptor for in vivo magnetic resonance imaging of hepatocellular carcinoma[J].Bioconjug Chem, 2017, 28 (11) :2794-2803.

[18]JIANG AL, GUO ZB, DING ZX.Expression and significance of VEGF-C in human hepatocellular carcinoma tissues[J].Chin J Cancer Prev Treat, 2009, 16 (13) :1006-1008. (in Chinese) 姜爱莲, 郭子博, 丁兆习.VEGF-C在人原发性肝细胞肝癌中的表达及意义[J].中华肿瘤防治杂志, 2009, 16 (13) :1006-1008.

施引文献

资源附件(0)

访问统计